Beta-Thalassemia Completed Phase 2 Trials for Deferasirox (DB01609)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00061763Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasTreatment
NCT00447694Cardiac T2* in Beta-thalassemia Patients on Deferasirox TreatmentTreatment